Editorial: Androgen-dependent diseases and their treatment

Editorial: Androgen-dependent diseases and their treatment

Saved in:

Bibliographic Details
Main Author:	Marisa Cabeza
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Endocrinology
Subjects:	androgen-dependent diseases metastatic castration-resistant prostate cancer (mCRPC) polycystic ovary syndrome (PCO) hyperandrogenism benign prostatic hyperplasia 11-oxygenated androgens
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1526537/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS
by: Yi-Ru Tsai, et al.
Published: (2025-04-01)

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-resistant prostate cancer
by: Zhiyu Zhang, et al.
Published: (2025-08-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy
by: Yingying Wu, et al.
Published: (2025-03-01)

Relationship between serum Prostate Specific Antigen (PSA) in women with polycystic ovary syndrome and some reproductive hormones in Kirkuk city
by: Marwa Ghazi Rifatt, et al.
Published: (2023-02-01)

Prognostic value of prostate-specific antigen in advanced prostate cancer treated with androgen deprivation therapy and abiraterone
by: L. Lou, et al.
Published: (2024-11-01)

Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01)

Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer
by: Ze Wang, et al.
Published: (2025-08-01)

Androgen receptor as a potential therapeutic target in castration-resistant prostate cancer: a bibliometric analysis (2005–2024)
by: Jiexiang Zhang, et al.
Published: (2025-07-01)

ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01)

Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01)

Euodia rutaecarpa fruit attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5α-reductase activity and androgen receptor signaling pathway
by: Yung Hyun Choi
Published: (2024-11-01)

Hovenia dulcis Honey Suppresses Androgen‐Induced Epithelial–Mesenchymal Transition in Benign Prostatic Hyperplasia
by: Buyun Kim, et al.
Published: (2025-05-01)

Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis
by: Azka Syed, et al.
Published: (2025-07-01)

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer
by: Maibritt Nørgaard, et al.
Published: (2025-04-01)

Advancements in Research on Non-AR- Signaling Pathways and Targeted Therapies for Castration-Resistant Prostate Cancer
by: Haq Dad, et al.
Published: (2025-01-01)

Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer
by: Li-Yang Wang, et al.
Published: (2025-05-01)

Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
by: Xia Sheng, et al.
Published: (2015-04-01)

Impact of interdisciplinary tumor boards (ITB) and personalized treatment on survival outcomes in metastatic castration-resistant prostate cancer
by: Laura Lawaczeck, et al.
Published: (2025-03-01)

Research progress on mechanisms of endocrine therapy resistance in prostate cancer
by: QI Zihao, et al.
Published: (2025-04-01)

Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
by: Yuqin Zhang, et al.
Published: (2025-07-01)

Androgens and severity of the new coronavirus infection course
by: A. A. Gritskevich, et al.
Published: (2022-06-01)

SLX1 silencing overcomes Olaparib resistance in metastatic castration-resistant prostate cancer by disrupting SLX4-mediated DNA repair complexes
by: Xin Zhao, et al.
Published: (2025-12-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)

Wnt5a augments intracellular free cholesterol levels and promotes castration resistance in prostate cancer
by: Yuqi Guo, et al.
Published: (2025-03-01)

Treatment patterns in hormone-sensitive metastatic prostate cancer: data from a referral hospital in Bogota, real-world evidence study
by: Juliana Arenas-Hoyos, et al.
Published: (2024-07-01)

Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer
by: Maria Malvina Tsamouri, et al.
Published: (2025-08-01)

Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer
by: Robert D. Marek, et al.
Published: (2024-11-01)

Does Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
by: Serkan Kahyaoglu, et al.
Published: (2023-08-01)

Editorial: Androgen receptors in male and female reproduction
by: Federica Barbagallo, et al.
Published: (2025-06-01)

Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis
by: Sharath Kumar, et al.
Published: (2025-08-01)

Spatial transcriptomics reveals Inhba/Smad2/E2f4 axis in Lrp2high thecal cell proliferation in androgen-induced PCOS mice
by: Man Luo, et al.
Published: (2025-08-01)

Androgen deprivation therapy and the risk of subsequent keratitis
by: Dai-Wei Liu, et al.
Published: (2021-01-01)

Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01)

The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
by: Xueming Huang, et al.
Published: (2025-06-01)

Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach
by: Almudena Zapatero, et al.
Published: (2025-07-01)

Protective effect of Yunkang oral liquid via regulating androgen receptor in polycystic ovary syndrome rats
by: Xiang Zheng, et al.
Published: (2024-12-01)

Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence
by: Mehdi Heidari Horestani, et al.
Published: (2024-12-01)